Exact Mass: 490.12978200000003

Exact Mass Matches: 490.12978200000003

Found 29 metabolites which its exact mass value is equals to given mass value 490.12978200000003, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

L-2-Aminoadipate adenylate

(2S)-2-amino-6-[({[(3S,4R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]-6-oxohexanoic acid

C16H23N6O10P (490.1213228)

L-2-Aminoadipate adenylate is an intermediate in Lysine biosynthesis. L-2-Aminoadipate adenylate is the 4th to last step in the synthesis of L-Lysine and is converted from L-2-Aminoadipate via the enzyme aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31). It is then converted to alpha-Aminoadipoyl-S-acyl enzyme via the enzyme aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31). [HMDB] L-2-Aminoadipate adenylate is an intermediate in Lysine biosynthesis. L-2-Aminoadipate adenylate is the 4th to last step in the synthesis of L-Lysine and is converted from L-2-Aminoadipate via the enzyme aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31). It is then converted to alpha-Aminoadipoyl-S-acyl enzyme via the enzyme aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31).

Tesevatinib

7-[[(3aS,6aR)-2-methyl-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-5-yl]methoxy]-N-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine

C24H25Cl2FN4O2 (490.1338501999999)

(1R,4aS,9aR,E)-3-(3,5-dihydroxystyryl)-6,8,9a-trihydroxy-1-(3,4,5-trihydroxyphenyl)-1,4,4a,9a-tetrahydrofluoren-9-one|syagrusin A

C27H22O9 (490.1263762)

nhatrangin B

C21H31BrO8 (490.1202186)

D009676 - Noxae > D011042 - Poisons > D008235 - Lyngbya Toxins D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins

Cys Cys Glu His

(4S)-4-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}butanoic acid

C17H26N6O7S2 (490.1304326)

Cys Cys His Glu

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]pentanedioic acid

C17H26N6O7S2 (490.1304326)

Cys Glu Cys His

(4S)-4-[(2R)-2-amino-3-sulfanylpropanamido]-4-{[(1R)-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}butanoic acid

C17H26N6O7S2 (490.1304326)

Cys Glu His Cys

(4S)-4-[(2R)-2-amino-3-sulfanylpropanamido]-4-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-(1H-imidazol-4-yl)ethyl]carbamoyl}butanoic acid

C17H26N6O7S2 (490.1304326)

Cys His Cys Glu

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]pentanedioic acid

C17H26N6O7S2 (490.1304326)

Cys His Glu Cys

(4S)-4-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}butanoic acid

C17H26N6O7S2 (490.1304326)

Glu Cys Cys His

(4S)-4-amino-4-{[(1R)-1-{[(1R)-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}butanoic acid

C17H26N6O7S2 (490.1304326)

Glu Cys His Cys

(4S)-4-amino-4-{[(1R)-1-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-(1H-imidazol-4-yl)ethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}butanoic acid

C17H26N6O7S2 (490.1304326)

Glu His Cys Cys

(4S)-4-amino-4-{[(1S)-1-{[(1R)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}-2-(1H-imidazol-4-yl)ethyl]carbamoyl}butanoic acid

C17H26N6O7S2 (490.1304326)

His Cys Cys Glu

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]pentanedioic acid

C17H26N6O7S2 (490.1304326)

His Cys Glu Cys

(4S)-4-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-4-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}butanoic acid

C17H26N6O7S2 (490.1304326)

His Glu Cys Cys

(4S)-4-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-{[(1R)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}butanoic acid

C17H26N6O7S2 (490.1304326)

Clindamycin B 2-Phosphate

C17H32ClN2O8PS (490.13054320000003)

AM966

C27H23ClN2O5 (490.1295418)

XL-647

Tesevatinib

C24H25Cl2FN4O2 (490.1338501999999)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D000970 - Antineoplastic Agents

N-(1-Cyanocyclopropyl)-3-({[(2S)-5-oxopyrrolidin-2-YL]methyl}sulfonyl)-N~2~-[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]-L-alaninamide

C20H22F4N4O4S (490.12978200000003)

Exact Mass: 490.12978200000003

Exact Mass Matches: 490.12978200000003

L-2-Aminoadipate adenylate

Tesevatinib

retipolide A 5-O-methyl ether

bergenin-8-O-alpha-L-rhamnoside

parvifloral F

Precercosporin

(1R,4aS,9aR,E)-3-(3,5-dihydroxystyryl)-6,8,9a-trihydroxy-1-(3,4,5-trihydroxyphenyl)-1,4,4a,9a-tetrahydrofluoren-9-one|syagrusin A

nhatrangin B

Cys Cys Glu His

Cys Cys His Glu

Cys Glu Cys His

Cys Glu His Cys

Cys His Cys Glu

Cys His Glu Cys

Glu Cys Cys His

Glu Cys His Cys

Glu His Cys Cys

His Cys Cys Glu

His Cys Glu Cys

His Glu Cys Cys

Clindamycin B 2-Phosphate

AM966

XL-647

N-(1-Cyanocyclopropyl)-3-({[(2S)-5-oxopyrrolidin-2-YL]methyl}sulfonyl)-N~2~-[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]-L-alaninamide

1-(2,1,3-benzothiadiazol-4-ylsulfonyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]piperidine-4-carboxamide

1-(4-Bromophenyl)-2-[3-[hydroxy(diphenyl)methyl]-1-azoniabicyclo[2.2.2]octan-1-yl]ethanone

20-Oxopregn-5-ene-3beta,21-diyl disulfate

L-2-Aminoadipate adenylate

21-hydroxypregnenolone disulfate(2-)